Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment

Introduction: Despite unequivocal evidence supporting the use of pre-exposure prophylaxis (PrEP), its scale-up has been gradual overall, and nearly absent among people who use drugs (PWUD). In the present study, we implemented the use of PrEP, as a part of an integrated HIV prevention approach, and...

Full description

Bibliographic Details
Main Authors: Roman Shrestha, Michael Copenhaver
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-07-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fpubh.2018.00195/full
id doaj-5615212b82cc4b93a841252c6051faa5
record_format Article
spelling doaj-5615212b82cc4b93a841252c6051faa52020-11-25T00:57:38ZengFrontiers Media S.A.Frontiers in Public Health2296-25652018-07-01610.3389/fpubh.2018.00195348187Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in TreatmentRoman Shrestha0Roman Shrestha1Michael Copenhaver2Michael Copenhaver3Department of Allied Health Sciences, University of Connecticut, Storrs, CT, United StatesInstitute for Collaboration on Health, Intervention, & Policy, University of Connecticut, Storrs, CT, United StatesDepartment of Allied Health Sciences, University of Connecticut, Storrs, CT, United StatesInstitute for Collaboration on Health, Intervention, & Policy, University of Connecticut, Storrs, CT, United StatesIntroduction: Despite unequivocal evidence supporting the use of pre-exposure prophylaxis (PrEP), its scale-up has been gradual overall, and nearly absent among people who use drugs (PWUD). In the present study, we implemented the use of PrEP, as a part of an integrated HIV prevention approach, and explored the experiences and attitudes related to PrEP use among PWUD.Methods: Between September 2016 and July 2017, we recruited 40 HIV-uninfected, methadone-maintained people, who reported HIV-risk behaviors, and were currently taking PrEP. We conducted both quantitative and in-depth semi-structured qualitative interviews that primarily focused on experiences, attitudes, acceptability, disclosure status, risk compensation-related attitudes, and barriers related to PrEP adherence.Results: Results showed that participants were highly satisfied and perceived PrEP as valuable and acceptable for HIV prevention. Participants reported high adherence to PrEP. The most highly endorsed facilitators to PrEP adherence were use of memory aids, no out-of-pocket cost, perceived benefit, and support from social network. The barriers to adherence included side-effects, stigmatization, requirement of daily dosing, and accessibility of PrEP services. Additionally, participants expressed disagreement with the overall risk compensation-related attitudes (i.e., decreased personal concern about engaging in HIV risk behavior due to their perception that PrEP is now fully protecting them from contracting HIV) and indicated no increased engagement in risk behaviors while on PrEP.Conclusions: The results from the current study provide preliminary evidence supporting the successful integration of PrEP within the substance abuse treatment setting, where high risk PWUD are concentrated.https://www.frontiersin.org/article/10.3389/fpubh.2018.00195/fullHIV preventionpre-exposure prophylaxispeople who use drugssubstance abusemethadone maintenance program
collection DOAJ
language English
format Article
sources DOAJ
author Roman Shrestha
Roman Shrestha
Michael Copenhaver
Michael Copenhaver
spellingShingle Roman Shrestha
Roman Shrestha
Michael Copenhaver
Michael Copenhaver
Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment
Frontiers in Public Health
HIV prevention
pre-exposure prophylaxis
people who use drugs
substance abuse
methadone maintenance program
author_facet Roman Shrestha
Roman Shrestha
Michael Copenhaver
Michael Copenhaver
author_sort Roman Shrestha
title Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment
title_short Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment
title_full Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment
title_fullStr Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment
title_full_unstemmed Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment
title_sort exploring the use of pre-exposure prophylaxis (prep) for hiv prevention among high-risk people who use drugs in treatment
publisher Frontiers Media S.A.
series Frontiers in Public Health
issn 2296-2565
publishDate 2018-07-01
description Introduction: Despite unequivocal evidence supporting the use of pre-exposure prophylaxis (PrEP), its scale-up has been gradual overall, and nearly absent among people who use drugs (PWUD). In the present study, we implemented the use of PrEP, as a part of an integrated HIV prevention approach, and explored the experiences and attitudes related to PrEP use among PWUD.Methods: Between September 2016 and July 2017, we recruited 40 HIV-uninfected, methadone-maintained people, who reported HIV-risk behaviors, and were currently taking PrEP. We conducted both quantitative and in-depth semi-structured qualitative interviews that primarily focused on experiences, attitudes, acceptability, disclosure status, risk compensation-related attitudes, and barriers related to PrEP adherence.Results: Results showed that participants were highly satisfied and perceived PrEP as valuable and acceptable for HIV prevention. Participants reported high adherence to PrEP. The most highly endorsed facilitators to PrEP adherence were use of memory aids, no out-of-pocket cost, perceived benefit, and support from social network. The barriers to adherence included side-effects, stigmatization, requirement of daily dosing, and accessibility of PrEP services. Additionally, participants expressed disagreement with the overall risk compensation-related attitudes (i.e., decreased personal concern about engaging in HIV risk behavior due to their perception that PrEP is now fully protecting them from contracting HIV) and indicated no increased engagement in risk behaviors while on PrEP.Conclusions: The results from the current study provide preliminary evidence supporting the successful integration of PrEP within the substance abuse treatment setting, where high risk PWUD are concentrated.
topic HIV prevention
pre-exposure prophylaxis
people who use drugs
substance abuse
methadone maintenance program
url https://www.frontiersin.org/article/10.3389/fpubh.2018.00195/full
work_keys_str_mv AT romanshrestha exploringtheuseofpreexposureprophylaxisprepforhivpreventionamonghighriskpeoplewhousedrugsintreatment
AT romanshrestha exploringtheuseofpreexposureprophylaxisprepforhivpreventionamonghighriskpeoplewhousedrugsintreatment
AT michaelcopenhaver exploringtheuseofpreexposureprophylaxisprepforhivpreventionamonghighriskpeoplewhousedrugsintreatment
AT michaelcopenhaver exploringtheuseofpreexposureprophylaxisprepforhivpreventionamonghighriskpeoplewhousedrugsintreatment
_version_ 1725223119745974272